Recurrent Gastric Cancer Terminated Phase 2 Trials for Romidepsin (DB06176)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098527FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction CancerTreatment